World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
24541
World Ranking
15161
National Ranking
7651

Cristina Magi-Galluzzi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Cristina Magi-Galluzzi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 373 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Cristina Magi-Galluzzi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Cristina Magi-Galluzzi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Cristina Magi-Galluzzi is affiliated with the University of Alabama at Birmingham in the United States. Their research primarily focuses on medical fields, with a strong emphasis on pulmonary and respiratory medicine, surgery, molecular biology, rheumatology, and radiology including nuclear medicine and imaging.

The scientist has contributed extensively to the study of prostate cancer and renal cell carcinoma, as well as other urologic and reproductive health conditions. Their main topics of work encompass:

  • Prostate Cancer Treatment and Research
  • Renal cell carcinoma treatment
  • Prostate Cancer Diagnosis and Treatment
  • Bladder and Urothelial Cancer Treatments
  • Renal and related cancers
  • Urinary and Genital Oncology Studies
  • Urologic and reproductive health conditions

Magi-Galluzzi has published frequently in several key journals, including:

  • Modern Pathology
  • Histopathology
  • The Journal of Urology
  • The American Journal of Surgical Pathology
  • Human Pathology

The following recent papers illustrate their contributions to genitourinary pathology and cancer diagnosis:

  • The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer, 2020, Archives of Pathology & Laboratory Medicine
  • New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia, 2021, Modern Pathology
  • Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia, 2021, Modern Pathology
  • Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: Guideline From the College of American Pathologists in Collaboration With the Association for Molecular Pathology and Fight Colorectal Cancer, 2022, Archives of Pathology & Laboratory Medicine
  • ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217, 2020, Modern Pathology

They collaborate regularly with several coauthors, including Kiril Trpkov, Rajal B. Shah, Sean R. Williamson, George J. Netto, and Maria Tretiakova. Coauthorship counts with these colleagues are significant, indicating ongoing collaborative research efforts.

Best Publications

  • A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.

    Jonathan I. Epstein;Michael J. Zelefsky;Daniel D. Sjoberg;Joel B. Nelson

  • The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia

    John R. Srigley;Brett Delahunt;John N. Eble;Lars Egevad

  • EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent

    Kexin Xu;Zhenhua Jeremy Wu;Anna C. Groner;Housheng Hansen He

  • The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters

    Brett Delahunt;John C. Cheville;Guido Martignoni;Peter A. Humphrey

  • Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant

    Anatoly Urisman;Ross J Molinaro;Ross J Molinaro;Nicole Fischer;Sarah J Plummer

  • A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling

    Eric A. Klein;Matthew R. Cooperberg;Cristina Magi-Galluzzi;Jeffry P. Simko

  • The Cell Cycle Inhibitor p27 Is an Independent Prognostic Marker in Small (T1a,b) Invasive Breast Carcinomas

    Puay Tan;Blake Cady;Molly Wanner;Peter Worland

  • Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies

    Dejan Knezevic;Audrey D Goddard;Nisha Natraj;Diana B Cherbavaz

  • Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients.

    Anthony J. Gill;Anthony J. Gill;Ondrej Hes;Thomas Papathomas;Monika Šedivcová

  • TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients.

    Cristina Magi-Galluzzi;Toyonori Tsusuki;Paul Elson;Kelly Simmerman

  • Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association

    Hakan Aydin;Cristina Magi-Galluzzi;Brian R. Lane;Linda Sercia

  • Saturation Technique Does Not Improve Cancer Detection as an Initial Prostate Biopsy Strategy

    J. Stephen Jones;Amit Patel;Lynn Schoenfield;John C. Rabets

  • International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease.

    Cristina Magi-Galluzzi;Andrew J Evans;Brett Delahunt;Jonathan I Epstein

  • RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1

    John R Prensner;Shuang Zhao;Nicholas Erho;Matthew Schipper

  • Clinical Validation of an Epigenetic Assay to Predict Negative Histopathological Results in Repeat Prostate Biopsies

    Alan W. Partin;Leander Van Neste;Eric A. Klein;Leonard S. Marks

  • Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis

    C. Magi-Galluzzi;R. Mishra;M. Fiorentino;R. Montironi

  • The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel

    Sean R Williamson;Brett Delahunt;Cristina Magi-Galluzzi;Ferran Algaba

  • Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis.

    Massimo Loda;Paola Capodieci;Rajesh Mishra;Hong Yao

  • Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients.

    Juan Guo;Maria S. Tretiakova;Megan L. Troxell;Adeboye O. Osunkoya

  • Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.

    Hakan Aydin;Longwen Chen;Liang Cheng;Susan Vaziri

Frequent Co-Authors

Eric A. Klein
Eric A. Klein Cleveland Clinic
Ming Zhou
Ming Zhou Baylor College of Medicine
Jonathan I. Epstein
Jonathan I. Epstein Johns Hopkins University
Rodolfo Montironi
Rodolfo Montironi Marche Polytechnic University
Jihad H. Kaouk
Jihad H. Kaouk Cleveland Clinic
Lars Egevad
Lars Egevad Karolinska Institute
Peter A. Humphrey
Peter A. Humphrey Yale University
Daniel M. Berney
Daniel M. Berney Barts Health NHS Trust
Liang Cheng
Liang Cheng Brown University
John C. Cheville
John C. Cheville Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always begin with traditional medical school. There are a variety of online degrees and bridge programs designed to help students advance in healthcare. For nurses, asn to fnp programs provide a streamlined path to becoming a Family Nurse Practitioner, opening doors to higher responsibility and pay.

Nutrition is another promising area. Earning an online bs in nutrition can lead to careers in public health, dietary counseling, and wellness coaching, and often serves as a stepping stone to further advanced degrees.

For those interested in leadership, online mha programs give you the expertise to excel in healthcare administration and management roles. These degrees are ideal for those looking to make systemic impacts in hospitals, clinics, or healthcare organizations.

Notably, there are best online rn to bsn programs without clinical requirements designed for working RNs to further their education without needing in-person clinical rotations, making advancement more accessible.

These online options provide flexible, accredited pathways for students at different stages in their healthcare journey.

Best Scientists Citing Cristina Magi-Galluzzi

Trending Scientists

Recently Published Articles